Cargando…
A Novel Bispecific Antibody against Human CD3 and Ephrin Receptor A10 for Breast Cancer Therapy
Ephrin receptor A10 (EphA10), a transmembrane receptor that binds to ephrin, is a newly identified breast cancer marker protein that has also been detected in HER2-negative tissue. In this study, we report creation of a novel bispecific antibody (BsAb) binding both EphA10 and CD3, thereby forming a...
Autores principales: | Taki, Shintaro, Kamada, Haruhiko, Inoue, Masaki, Nagano, Kazuya, Mukai, Yohei, Higashisaka, Kazuma, Yoshioka, Yasuo, Tsutsumi, Yasuo, Tsunoda, Shin-ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682974/ https://www.ncbi.nlm.nih.gov/pubmed/26678395 http://dx.doi.org/10.1371/journal.pone.0144712 |
Ejemplares similares
-
Evaluation of silica nanoparticle binding to major human blood proteins
por: Hata, Katsutomo, et al.
Publicado: (2014) -
Expression of Eph receptor A10 is correlated with lymph node metastasis and stage progression in breast cancer patients
por: Nagano, Kazuya, et al.
Publicado: (2013) -
Size and surface modification of amorphous silica particles determine their effects on the activity of human CYP3A4 in vitro
por: Imai, Shunji, et al.
Publicado: (2014) -
Intestinal absorption and biological effects of orally administered amorphous silica particles
por: Yoshida, Tokuyuki, et al.
Publicado: (2014) -
Creation of mouse TNFR2-selective agonistic TNF mutants using a phage display technique
por: Ando, Daisuke, et al.
Publicado: (2016)